THE SHARE: Change: 0.00 SEK (-0.27%) / Price: 0.18 SEK / May 21, 2025, 5:25 pm (CEST)
  • Home
  • About
    • Introduction
    • Board of Directors
    • Management Team
    • Medical Advisors
    • Corporate Governance
    • Career
  • Technology
    • Physiological Targeting
    • Functional Nanoparticles
    • Publications
    • Patent
  • Portfolio
    • Pipeline
    • SpagoPix
    • Tumorad
  • Investor Relations
    • The Share
    • Analyst Coverage
    • Owners
    • Financial Reports
    • Financial Calendar
    • Equity research
    • Shareholder’s Personal Data
    • Share Issue
  • Media
    • Spago Nanomedical in media
    • Press Releases
    • Subscribe
    • Presentations
    • Events
    • Image Bank
  • Contact
    • Contact us

Shares

  • 31 May, 2024
    Spago Nanomedical announces outcome of the exercise of warrants series TO12
  • 31 May, 2024
    Spago Nanomedical offentliggör utfall av nyttjande av teckningsoptioner serie TO12
  • 25 Jan, 2024
    Företrädesemissionen och den riktade emissionen till vissa garanter i Spago Nanomedical slutregistrerade
  • 25 Jan, 2024
    The rights issue and the directed share issue to certain guarantors in Spago Nanomedical fully registered
  • 13 Dec, 2023
    Spago Nanomedical genomför riktad nyemission av aktier till garanter efter den genomförda företrädesemissionen
  • 13 Dec, 2023
    Spago Nanomedical carries out a directed issue of shares to guarantors following the completed rights issue
  • 12 Dec, 2023
    Företrädesemissionen i Spago Nanomedical delregistrerad
  • 12 Dec, 2023
    Rights issue in Spago Nanomedical partially registered
  • 27 Nov, 2023
    Spago Nanomedical offentliggör utfall i företrädesemissionen
  • 27 Nov, 2023
    Spago Nanomedical announces outcome of the rights issue
  • 1
  • 2
  • 3
  • 4
  • Next
Back

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn

Member of:

Copyright © 2025 Spago Nanomedical AB. All Rights Reserved.
Design by Clavis Communications